In what clinical scenarios do you find ctDNA helpful for managing skin cancer?  

How are clinicians using circulating tumor DNA (ctDNA) to guide management of skin cancers such as melanoma, MCC, or advanced NMSC, and in what situations has it influenced your treatment decisions?